{
    "root": "77f966b6-f1ac-4e1d-8937-a10f72241d5a",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ciprofloxacin",
    "value": "20250228",
    "ingredients": [
        {
            "name": "CIPROFLOXACIN HYDROCHLORIDE",
            "code": "4BA73M5E37",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_100241"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "CORN OIL",
            "code": "8470G57WFM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_195250"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "indications": {
        "text": "ciprofloxacin tablets fluoroquinolone antibacterial indicated adults ( 18 years age older ) following infections caused designated , susceptible bacteria pediatric patients indicated : \u2022 skin skin structure infections ( 1.1 ) \u2022 bone joint infections ( 1.2 ) \u2022 complicated intra-abdominal infections ( 1.3 ) \u2022 infectious diarrhea ( 1.4 ) \u2022 typhoid fever ( enteric fever ) ( 1.5 ) \u2022 uncomplicated cervical urethral gonorrhea ( 1.6 ) \u2022 inhalational anthrax post-exposure adult pediatric patients ( 1.7 ) \u2022 plague adult pediatric patients ( 1.8 ) \u2022 chronic bacterial prostatitis ( 1.9 ) \u2022 lower respiratory tract infections ( 1.10 ) acute exacerbation chronic bronchitis \u2022 urinary tract infections ( 1.11 ) urinary tract infections ( uti ) acute uncomplicated cystitis complicated uti pyelonephritis pediatric patients \u2022 acute sinusitis ( 1.12 ) usage reduce development drug-resistant bacteria maintain effectiveness ciprofloxacin tablets antibacterial drugs , ciprofloxacin tablets used treat prevent infections proven strongly suspected caused bacteria . ( 1.13 )",
        "doid_entities": [
            {
                "text": "infectious diarrhea (DOID:12384)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12384"
            },
            {
                "text": "diarrhea (DOID:13250)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13250"
            },
            {
                "text": "typhoid (DOID:13258)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13258"
            },
            {
                "text": "gonorrhea (DOID:7551)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7551"
            },
            {
                "text": "plague (DOID:3482)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3482"
            },
            {
                "text": "prostatitis (DOID:14654)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_14654"
            },
            {
                "text": "chronic bronchitis (DOID:6132)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6132"
            },
            {
                "text": "uti (DOID:0080784)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080784"
            },
            {
                "text": "cystitis (DOID:1679)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1679"
            },
            {
                "text": "pyelonephritis (DOID:11400)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11400"
            },
            {
                "text": "sinusitis (DOID:0050127)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050127"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute uncomplicated cystitis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_156149"
            },
            {
                "disease": "chronic bacterial prostatitis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_330064"
            }
        ]
    },
    "contraindications": {
        "text": "ciprofloxacin tablets administered orally described appropriate guidelines tables .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ciprofloxacin tablets , usp available white medium capsule shape film-coated tablet containing 500 mg ciprofloxacin . 500 mg tablet engraved \u201c ww928 \u201d one side plain side . bottles 6 tablets ndc 68788-7864-0 bottles 10 tablets ndc 68788-7864-8 bottles 14 tablets ndc 68788-7864-1 bottles 20 tablets ndc 68788-7864-2 bottles 30 tablets ndc 68788-7864-3 bottles 40 tablets ndc 68788-7864-4 bottles 60 tablets ndc 68788-7864-6 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "\u2022 known hypersensitivity ciprofloxacin tablets quinolones ( 4.1 , 5.6 , 5.7 ) \u2022 concomitant tizanidine ( 4.2 )",
    "indications_original": "Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: \u2022\u00a0 Skin and Skin Structure Infections ( 1.1 ) \u2022\u00a0 Bone and Joint Infections ( 1.2 ) \u2022\u00a0 Complicated Intra-Abdominal Infections ( 1.3 ) \u2022\u00a0 Infectious Diarrhea ( 1.4 ) \u2022 \u00a0Typhoid Fever (Enteric Fever) ( 1.5 ) \u2022\u00a0 Uncomplicated Cervical and Urethral Gonorrhea ( 1.6 ) \u2022\u00a0 Inhalational Anthrax post-exposure in adult and pediatric patients ( 1.7 ) \u2022\u00a0 Plague in adult and pediatric patients ( 1.8 ) \u2022\u00a0 Chronic Bacterial Prostatitis ( 1.9 ) \u2022\u00a0 Lower Respiratory Tract Infections ( 1.10) o\u00a0 Acute Exacerbation of Chronic Bronchitis \u2022\u00a0 Urinary Tract Infections ( 1.11 ) o\u00a0 Urinary Tract Infections (UTI) o\u00a0 Acute Uncomplicated Cystitis o\u00a0 Complicated UTI and Pyelonephritis in Pediatric Patients \u2022 \u00a0Acute Sinusitis ( 1.12 ) Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of ciprofloxacin tablets and other antibacterial drugs, ciprofloxacin tablets should be used only to treat or prevent infections that are proven or strongly\u00a0suspected to be caused by bacteria. ( 1.13 )",
    "contraindications_original": "Ciprofloxacin tablets\u00a0should be administered orally as described in the appropriate Dosage Guidelines tables.",
    "warningsAndPrecautions_original": "Ciprofloxacin Tablets, USP are available as white medium capsule shape film-coated tablet containing 500 mg ciprofloxacin. The 500 mg tablet is engraved with \u201cWW928\u201d from one side and plain from the other side.\n                  \n                     \n                        \u00a0Bottles of 6 Tablets\tNDC 68788-7864-0\n                     \n                        \u00a0Bottles of 10 Tablets\tNDC 68788-7864-8\n                     \n                        \u00a0Bottles of 14 Tablets\tNDC 68788-7864-1\n                     \n                        \u00a0Bottles of 20 Tablets\tNDC 68788-7864-2\n                     \n                        \u00a0Bottles of 30 Tablets\tNDC 68788-7864-3\n                     \n                        \u00a0Bottles of 40 Tablets\tNDC 68788-7864-4\n                     \n                        \u00a0Bottles of 60 Tablets\tNDC 68788-7864-6\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "\u2022 Known hypersensitivity to ciprofloxacin tablets or other quinolones ( 4.1 , 5.6 , 5.7 ) \u2022 Concomitant administration with tizanidine ( 4.2 )",
    "drug": [
        {
            "name": "Ciprofloxacin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_100241"
        }
    ]
}